by May Khan | Oct 21, 2025 | en
Tradurre in Italiano From Rome to the World: How Italian Transparency Obligations Extend Internationally Table of content Italian HCPs Interacting with Foreign Companies Foreign Professionals Operating in Italy Italian HCPs Abroad Cross-Border Research and Trials...
by Sabrina Morgan | Oct 16, 2025 | en
Tradurre in Italiano 5 Common Mistakes to Avoid in First-Year Sunshine Reporting Table of content 1. Overlooking the Importance of Detailed “Nature of Spend” Categorization 2. Duplicate and Overlapping Transactions 3. Misaligned Reporting Periods 4. Currency and Value...
by May Khan | Oct 2, 2025 | en
Tradurre in Italiano The Role of an Intermediary or Third-Party Under the Italian Sunshine Act Table of content Intermediaries: Broader Than You Think Responsibility Rests With the Company Navigating Corporate Complexity Industry Guidance vs. Ministry Expectations...
by May Khan | Sep 26, 2025 | en
Tradurre in Italiano France’s Loi Bertrand vs. Italy’s Sunshine Act: Similarities and Divergences Table of content Similarities Between France and Italy’s Sunshine Laws Key Differences Between French and Italian Sunshine Acts The French Anti-Gift Law: Another...
by Mauro Teresi | Sep 16, 2025 | en
Tradurre in Italiano Non-Reportable Transfers of Value: 10 Scenarios You Don’t Need to Disclose Part 2/2 Table of content 1. Donations to non-health NGOs 2. Patient education materials co-developed with HCPs 3. AI-based diagnostic tools for pilot use 4. Institutional...
by May Khan | Sep 13, 2025 | en
Tradurre in Italiano GDPR and Italian Sunshine Act: How to Balance Transparency and Data Protection Table of content The GDPR Perspective The Italian Sunshine Act Perspective Practical Steps for Life Science Companies Legal Basis and Consent Data Retention...
